Literature DB >> 4514302

Acetylation of sickle cell hemoglobin by aspirin.

I M Klotz, J W Tam.   

Abstract

Incubation of HbS (or HbA) with aspirin leads to incorporation of acetyl groups into the protein. Incorporation was followed by the use of aspirin labeled with (14)C in the acetyl group. The acetylated hemoglobins show an increase in oxygen affinity compared to the parent proteins. If acetylation also occurs in vivo, administration of aspirin might ameliorate the severity of sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4514302      PMCID: PMC433486          DOI: 10.1073/pnas.70.5.1313

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Hemoglobin F1, an acetyl-containing hemoglobin.

Authors:  W A SCHROEDER; J T CUA; G MATSUDA; W D FENNINGER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

2.  X-ray diffraction study of binding of 2,3-diphosphoglycerate to human deoxyhaemoglobin.

Authors:  A Arnone
Journal:  Nature       Date:  1972-05-19       Impact factor: 49.962

3.  In vitro acetylation of plasma proteins, enzymes and DNA by aspirin.

Authors:  R N Pinckard; D Hawkins; R S Farr
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

4.  Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group.

Authors:  R M Bookchin; P M Gallop
Journal:  Biochem Biophys Res Commun       Date:  1968-07-11       Impact factor: 3.575

5.  Urea, urease, cyanate, and the sickling of hemoglobin S.

Authors:  R M Nalbandian; B M Nichols; E J Stehouwer; F R Camp
Journal:  Clin Chem       Date:  1972-09       Impact factor: 8.327

6.  Acetylated hemoglobins in feline blood.

Authors:  P Taketa; M H Attermeier; G A Mauk
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

7.  The interaction of hemoglobin and its subunits with 2,3-diphosphoglycerate.

Authors:  R Benesch; R E Benesch; Y Enoki
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

8.  The interaction of 2,3-diphosphoglycerate with various human hemoglobins.

Authors:  H F Bunn; R W Briehl
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

9.  Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.

Authors:  P N Gillette; J M Manning; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

10.  A reaction of glucose with peptides.

Authors:  H B Dixon
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

View more
  10 in total

1.  The sickling process in relation to clinical manifestations.

Authors:  A J Bellingham
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

2.  The effect of aspirin on sickling and oxygen affinity of erythrocytes.

Authors:  F G De Furia; A Cerami; H F Bunn; Y S Lu; C M Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

3.  Abnormal precipitation of oxyhemoglobin S by mechanical shaking.

Authors:  T Asakura; T Onishi; S Friedman; E Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

4.  Management of sickle-cell disease.

Authors:  J Stuart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

5.  The acetylation of hemoglobin by aspirin. In vitro and in vivo.

Authors:  K R Bridges; G J Schmidt; M Jensen; A Cerami; H F Bunn
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 6.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

7.  Noncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling.

Authors:  M R Waterman; K Yamaoka; L Dahm; J Taylor; G L Cottam
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

8.  Sites of acetylation of sickle cell hemoglobin by aspirin.

Authors:  M Shamsuddin; R G Mason; J M Ritchey; G R Honig; I M Klotz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.

Authors:  J A Walder; R H Zaugg; R S Iwaoka; W G Watkin; I M Klotz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling.

Authors:  Akito Nakagawa; Francine E Lui; Dina Wassaf; Revital Yefidoff-Freedman; Dominick Casalena; Michelle A Palmer; Jacqueline Meadows; Andrea Mozzarelli; Luca Ronda; Osheiza Abdulmalik; Kenneth D Bloch; Martin K Safo; Warren M Zapol
Journal:  ACS Chem Biol       Date:  2014-08-11       Impact factor: 5.100

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.